HYPD
Hyperion DeFi, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$3.30
+0.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 1.4M | 813.5K | 57.3K | 3.8K | — |
| Cost of Revenue | 303.2K | 303.3K | 3.9M | 16.0K | — |
| Gross Profit | 1.1M | 510.2K | (3.9M) | (12.2K) | — |
| Operating Expenses | |||||
| R&D Expense | 908.1K | 1.9M | 14.5M | 13.0M | 13.4M |
| SG&A Expense | 14.6M | 17.2M | 14.3M | 12.4M | 14.5M |
| General & Admin Expense | 11.7M | 17.2M | 13.6M | 11.3M | 13.2M |
| Selling & Marketing Expense | (37.1K) | — | 747.3K | 1.1M | 1.4M |
| Other Expenses | 909.8K | 405.3K | 16.1M | — | (994.1K) |
| Total Operating Expenses | 16.4M | 19.5M | 44.9M | 25.4M | 26.9M |
| Cost and Expenses | 16.7M | 19.8M | 48.8M | 25.4M | 26.9M |
| Operating Income (EBIT) | (15.3M) | (19.0M) | (48.7M) | (25.4M) | (26.9M) |
| Non-Operating | |||||
| Interest Income | 633.7K | 240.0K | 254.0K | 693.6K | 83.3K |
| Interest Expense | 907.5K | 1.6M | 2.5M | 2.4M | 1.4M |
| Net Interest Income | (273.8K) | (1.3M) | (2.2M) | (1.7M) | (1.3M) |
| Other Non-Op Income/Expense | 22.0M | (26.3M) | (1.1M) | (1.9M) | (1.1M) |
| Non-Operating Income (excl Interest) | 11.0M | 24.8M | (1.4M) | (517.2K) | (280.4K) |
| EBT (Pre-Tax Income) | 6.7M | (45.3M) | (49.8M) | (27.3M) | (28.0M) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | 6.7M | (45.3M) | (49.8M) | (27.3M) | (28.0M) |
| Earnings from Cont. Ops | 6.7M | (45.3M) | (49.8M) | (27.3M) | (28.0M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (20.0M) | (47.0M) | (49.8M) | (27.3M) | (28.0M) |
| Per Share | |||||
| Basic EPS | ($3.13) | ($9.40) | ($59.81) | ($53.15) | ($66.40) |
| Diluted EPS | ($3.22) | ($9.40) | ($59.81) | ($53.15) | ($66.40) |
| Revenue Per Share | $0.10 | $0.16 | $0.07 | $0.01 | $0.00 |
| Shares | |||||
| Basic Shares Outstanding | 14.2M | 5.0M | 832997 | 512912 | 420621 |
| Diluted Shares Outstanding | 17.1M | 5.0M | 832997 | 512912 | 420621 |
| Profitability Metrics | |||||
| EBITDA | (26.3M) | (43.8M) | (46.2M) | (24.1M) | (26.3M) |
| D&A | — | — | 1.1M | 783.2K | 307.4K |
| EBIT | (26.3M) | (43.8M) | (47.3M) | (24.9M) | (26.6M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026